Company: STAA
Filing Date: 2025-09-16
Form Type: DEFM14A
Source: 0001193125-25-204396
Chunk: 78

Company: STAAR SURGICAL CO
Filing Date: 2025-09-16
Form: DEFM14A
Chunk 78
---
 release indicating, among other things, that Broadwood
intends to vote against the Merger Proposal.

On September 15, 2025, Broadwood and other members of the Broadwood Group filed a
preliminary proxy statement with the SEC to solicit votes of STAAR stockholders in opposition to the Board’s recommendations on the Merger Proposal and Compensation Proposal presented in this proxy statement.

As of the filing of this proxy statement, STAAR has not received an Acquisition Proposal that the Board has determined constitutes, or could
reasonably be expected to lead to, a Superior Offer.

-47-

Recommendation of the Board and Reasons for the Merger Recommendation of the Board The Board has unanimously determined that the Merger Agreement and the transactions contemplated thereby, including the Merger, on the terms and subject to the conditions set forth in the Merger Agreement, are advisable, fair to and in the best interests of STAAR and its stockholders, approved, adopted and declared advisable the execution and delivery of, and entry into, the Merger Agreement, and directed that the Merger Agreement be submitted to the STAAR stockholders for adoption at the Special Meeting. The Board unanimously recommends that you vote: (1) “FOR” the Merger Proposal and (2) “FOR” the Compensation Proposal. Reasons for the Merger In evaluating the transactions contemplated by the Merger Agreement, including the Merger, the Board consulted with STAAR management and STAAR’s outside legal and financial advisors and, in reaching its determinations and making its recommendations, the Board considered a number of factors, including the following:

| • |     | Value of Merger Consideration Relative to Value of Standalone Prospects of STAAR. The Board considered the                                                                                                                                         
 opportunities, risks and uncertainties inherent in STAAR’s ability to execute its standalone business plan as an independent public company, and its belief that $28.00 per share in cash represents an attractive and comparatively certain value 
 for STAAR stockholders relative to the risk-adjusted prospects for STAAR on a standalone basis. Specifically, among other things, the Board considered:                                                                                            |

| • |     | the Board’s knowledge of the business, assets, operations, financial condition, earnings and prospects of                     
 STAAR, as well as the Board’s knowledge of the current and prospective environment in which STAAR and its businesses operate; |

| • |     | the fact that the price of STAAR’s common stock has decreased over the last several years, with a                                                                                                                                             
 significant decline in the